| Mary R Hutton Eyer, ARNP | |
|
2620 Wheaton Way, Bremerton, WA 98310-3335 | |
| (360) 377-3923 | |
| (360) 373-4988 |
| Full Name | Mary R Hutton Eyer |
|---|---|
| Gender | Female |
| Speciality | Nurse Practitioner - Adult Health |
| Location | 2620 Wheaton Way, Bremerton, Washington |
| Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1134488323 | NPI | - | NPPES |
| 1134488323 | Medicaid | WA |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 363LA2200X | Nurse Practitioner - Adult Health | AP 60279349 (Washington) | Primary |
| Entity Name | Olympic Internal Medicine, Inc., P.s. |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1861624876 PECOS PAC ID: 1456497072 Enrollment ID: O20091012000342 |
News Archive
In a new online survey of 15,559 Internet users in China findings show that more than fifty percent smokers find it difficult to quit the habit without professional assistance. This survey came in the wake of the World No Tobacco Day observed on the 31st of May and supported by the media center of the Ministry of Health and the Life Times newspaper.
Change can be hard for many people. For kids - who often thrive on routine and predictability - the transition from school year to summer and into a new academic year can bring uncertainty that can trigger anxiety and behavioral problems.
The Chicago Tribune published a series of articles on industry's solutions for health care reform. The paper "turned to Chicago-area leaders in three key segments of the industry: insurers, medical providers and pharmacy," and presented their "thoughts on how best to expand medical-care coverage to all Americans."
AtheroNova Inc., a biotech company focused on the research and development of compounds to safely regress atherosclerotic plaque and improve lipid profiles in humans, today announces that its partner, CardioNova, has accomplished first dosing of subjects for its Phase 1b clinical trial with AtheroNova's lead compound, AHRO-001.
Fresenius Kabi Pharmaceuticals Holding, Inc., announced today that APP Pharmaceuticals will immediately begin marketing Letrozole Tablets in the U.S., after the U.S. Food and Drug Administration granted approval to market the breast cancer treatment medication to Fresenius Kabi Oncology Limited.
› Verified 7 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Mary R Hutton Eyer, ARNP 2620 Wheaton Way, Bremerton, WA 98310-3319 Ph: (360) 377-3923 | Mary R Hutton Eyer, ARNP 2620 Wheaton Way, Bremerton, WA 98310-3335 Ph: (360) 377-3923 |
News Archive
In a new online survey of 15,559 Internet users in China findings show that more than fifty percent smokers find it difficult to quit the habit without professional assistance. This survey came in the wake of the World No Tobacco Day observed on the 31st of May and supported by the media center of the Ministry of Health and the Life Times newspaper.
Change can be hard for many people. For kids - who often thrive on routine and predictability - the transition from school year to summer and into a new academic year can bring uncertainty that can trigger anxiety and behavioral problems.
The Chicago Tribune published a series of articles on industry's solutions for health care reform. The paper "turned to Chicago-area leaders in three key segments of the industry: insurers, medical providers and pharmacy," and presented their "thoughts on how best to expand medical-care coverage to all Americans."
AtheroNova Inc., a biotech company focused on the research and development of compounds to safely regress atherosclerotic plaque and improve lipid profiles in humans, today announces that its partner, CardioNova, has accomplished first dosing of subjects for its Phase 1b clinical trial with AtheroNova's lead compound, AHRO-001.
Fresenius Kabi Pharmaceuticals Holding, Inc., announced today that APP Pharmaceuticals will immediately begin marketing Letrozole Tablets in the U.S., after the U.S. Food and Drug Administration granted approval to market the breast cancer treatment medication to Fresenius Kabi Oncology Limited.
› Verified 7 days ago
Teri Lynae Scott, ARNP, CWCN Nurse Practitioner Medicare: Not Enrolled in Medicare Practice Location: 2520 Cherry Ave, Bremerton, WA 98310 Phone: 360-744-5618 Fax: 360-744-4559 | |
Ms. Gretchen Cornwall Berni, ARNP Nurse Practitioner Medicare: Not Enrolled in Medicare Practice Location: 2709 Hemlock St, Bremerton, WA 98310 Phone: 360-782-6000 Fax: 360-478-7240 | |
Elizabeth J Shaubell, ARNP Nurse Practitioner Medicare: Not Enrolled in Medicare Practice Location: One Boone Road, Naval Hospital, Bremerton, WA 98312 Phone: 360-475-4379 Fax: 360-475-4646 | |
Theresa A Danscuk-sloan, WHNP Nurse Practitioner Medicare: Not Enrolled in Medicare Practice Location: One Boone Road, Bremerton, WA 98312 Phone: 360-475-4426 Fax: 360-475-4344 | |
Mrs. Mary Kathryn Odahl Heli, NURSE PRACTITIONER Nurse Practitioner Medicare: Not Enrolled in Medicare Practice Location: 1 Boone Rd, Bremerton, WA 98312 Phone: 360-475-4209 | |
Mrs. Carolyn Howard Ellison, APRN-C Nurse Practitioner Medicare: Medicare Enrolled Practice Location: 1 Boone Rd, Bremerton, WA 98312 Phone: 360-475-5540 | |
Chante Concepcion, NP-C Nurse Practitioner Medicare: Not Enrolled in Medicare Practice Location: 723 Ne Riddell Rd Ste A, Bremerton, WA 98310 Phone: 800-769-0045 |